IMPACT™
IMPACT™ (Intein Mediated Purification with an Affinity Chitin-binding Tag) is a novel protein purification system which utilizes the inducible self-cleavage activity of a protein splicing element (termed intein) to separate the target protein from the affinity tag. It distinguishes itself from all other purification systems by its ability to purify, in a single chromatographic step, a native recombinant protein without the use of a protease (1,2). A target protein is fused to a tag consisting of the intein and the chitin binding domain which allows affinity purification of the fusion protein on a chitin column. In the presence of thiols such as DTT or 2-mercaptoethanesulfonic acid (MESNA), the intein undergoes specific self-cleavage which releases the target protein from the chitin-bound intein tag resulting in a single-column purification of the target protein. In addition, with the use of pTXB1, native recombinant proteins that possess a reactive C-terminal thioester can be isolated for applications including protein ligation, semisynthesis and site-specific labeling (3,4).
The IMPACT™ Kit (NEB #E6901) contains expression vectors which allow fusion of the cleavable intein tag to either the C-terminus or N-terminus of the target protein. This flexibility in fusion protein construction maximizes the probability of successful expression and purification of a target protein.
(1) Chong, S. et al. (1997) Gene, 192, 277–281. PMID: 9224900
(2) Chong, S. et al. (1998) Nucl. Acids Res. 26, 5109–5115. PMID: 9801307
(3) Evans, T.C. et al. (1998) Protein Science, 7, 2256–2264. PMID: 9827992
(4) Muir, T.W., Sondhi, D. and Cole, P.A. (1998) Proc. Natl. Acad. Sci. USA, 95, 6705–6710. PMID: 9618476
(5) Dubendorff, J.W. and Studier, F.W. (1991) J. Mol. Biol., 219, 45–59. PMID: 1902522
(6) Ghosh, I. et al. (2004) J. of Imm. Methods, 293, 85–95. PMID: 15541279
(7) Xu, J. et al. (2004) BioTechniques, 36, 976–978. PMID: 15211748
(8) Kochinyan, S. et al. (2007) BioTechniques, 42, 63–69. PMID: 17269486
(9) Sun, L. et al. (2004) BioTechniques, 37, 430–443.
(10) Sun, L. et al. (2007) Methods, 42, 220–226. PMID: 17532508
IMPACT™ is a trademark of New England Biolabs, Inc.
Choose Type:
- Affinity Purification and On-column Cleavage (E6901)
- Construction of the Fusion Plasmid (E6901)
- Fusion Protein Expression (E6901)
- Isolation of CBD-fusion protein using Chitin Magnetic Beads
- Isolation of MBP-fusion protein using Amylose Magnetic Beads
- Preparation of Media and Solutions (E6901)
- Primer Design for Restriction Enzyme Cloning (E6901)
- Simplified Expression and Purification Protocol (E6901)
- Protein Expression with T7 Strains
- Expression Using SHuffle®
- Fusion Constructs (E6901)
-
Avoid Common Obstacles in Protein Expression
Read how to avoid common obstacles in protein expression that prevent interactions with cellular machinery.
- Competent Cells Brochure
- Protein Expression & Purification Brochure
- Competent Cell Product Comparison
- IMPACT™ Vectors and Applications
- Protein Expression and Purification Selection Chart
- Convenient Formats of Competent Cells
Feature Articles
Brochures
Selection Tools
Usage Guidelines
- Yields proteins with native sequence
- One-step affinity purification with no additional steps to remove affinity tag
- Release from the fusion partner without the use of proteases
- Fusion to either the C-terminus or N-terminus of the target protein
- The ability to label the C-terminus of the target protein
- T7 Promoter for higher levels of expression and tight transcriptional control
- The ability to introduce non-coded amino acids, fatty acids or chemically modified amino acid residues (segmental labeling of proteins for NMR analysis)
Lane 2: induced cell extract showing expressed fusion protein.
Lane 3: MBP fractions eluted after inducing cleavage overnight at 4°C.
Lane 4: MBP ligated to a peptide containing an N-terminal cysteine. Marker M is the Protein Ladder (NEB #P7703)
While NEB develops and validates its products for various applications, the use of this product may require the buyer to obtain additional third party intellectual property rights for certain applications.
For more information about commercial rights, please contact NEB's Global Business Development team at [email protected].
This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
